Sponsor:
AstraZeneca
Code:
NCT06346392
Conditions
Gastric Cancer
Gastroesophageal Junction Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AZD0901
AZD0901
Ramucirumab+ paclitaxel
Paclitaxel
Docetaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-02. This information was provided to ClinicalTrials.gov by AstraZeneca on 2025-05-09.